European Archives - Page 843 of 1137 - European Medical Journal

Psychological Barriers Help Explain Low Rates of Breastfeeding Amongst Obese Women

Breastfeeding is far less common among obese women, thereby increasing the risk of their children subsequently developing obesity, according to research…

Study Identifies Biomarkers of Kidney Damage Following Cystic Fibrosis Treatment

Possible new biomarkers of kidney damage that occurs after antibiotic treatment for cystic fibrosis have been uncovered by researchers from the…

This March 2018, EMJ Supports

This March, EMJ has proudly showcased its support for World Kidney Day and World Tuberculosis (TB) Day. World Kidney Day is a global event…

Analysis of Skeleton Reveals Fresh Insights into Bone Diseases

New insights into the genetics of a range of bone diseases have been revealed following the DNA analysis of unusual skeletal remains of a fetus…

Innovative Brain Scanner Enables Measurement of Activity During Movement

An innovative scanner that enables brain activity to be measured during natural movements has been developed by researchers from the University of…

Screening for Prostate Cancer: CAP Trial Findings

New insights into screening for prostate cancer have been uncovered as a result of the Cluster Randomised Trial of PSA Testing for Prostate Cancer (CAP)…

Advances in Prostate Cancer Diagnosis: Validated Cut-Off Value

Distinguishing healthy tissues from cancerous tissues in prostate cancer patients with a high degree of specificity and sensitivity has been shown to be…

Novel Scanning Technology Reducing the Need for Liver Biopsy

LIVERMULTISCAN™, Perspectum Diagnostics, Ltd., Oxford, UK, was evaluated in a collaborative study by multiple UK Universities to assess the feasibility…

A Low-Carb Solution for Fatty Liver Disease

A carbohydrate-restricted diet has long been championed as an effective weight loss tool, but new research from the KTH Royal Institute of Technology…

An Interview with Karsten Kissel, Head Global Medical Affairs Biosimilars, Boehringer Ingelheim

What attracted me to the pharma industry was the opportunity to shape the development and implementation of treatments on a much broader scale than I…